StaphOff Biotech
0 followers
StaphOff has developed a completely unique approach to fighting staphylococcal infections using a first-in-class heptapeptide known as RNAIII Inhibiting Peptide (RIP) or CEN-101, and non-peptide analogues like CEN-103.
Org chart
Founder & Acting CEO
Collapse
Acting CFO
VP, Sales, Argentina
VP, Sales, South East Asia
Marketing Specialist
Board & advisors
Advisor
Advisor
Advisor
